Compounds for inhibiting insulin secretion and methods...

Details Compounds for inhibiting insulin secretion and methods... Compounds for inhibiting insulin secretion and methods...

2005-10-25

2005-10-25

Davis, Zinna Northington (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S330000, C514S364000, C514S617000, C546S217000, C546S225000, C548S134000, C564S161000, C564S180000

Reexamination Certificate

active

06958352

ABSTRACT:
Compounds, compositions and methods for altering insulin secretion, particularly in the context of treatment of subjects having, or suspected of being at risk for having, diabetes mellitus. The compounds have the following structure (I):including stereoisomers, prodrugs and pharmaceutically acceptable salts thereof, wherein W1, W2, X, R1, R2, R3, R4, m and n are defined herein.

REFERENCES:
patent: 467435 (1991-06-01), None
patent: WO 87/07891 (1987-12-01), None
patent: WO 00/71511 (2000-11-01), None
patent: WO 02/24204 (2002-03-01), None
Baron and Thayer, “CGP37157 Modulates Mitochondrial Ca2+Homeostasis in Cultured Rat Dorsal Root Ganglion Neurons,”Eur. J. Pharmacol. 340(2-3):295-300, Dec. 11, 1997.
Chiesi et al., “Structural Dependency of the Inhibitory Action of Benzodiazepines and Related Compounds on the Mitochondrial Na+-Ca2+Exchanger,”Biochem. Pharmacol. 37(22):4399-4403, Nov. 15, 1988.
Cox and Matlib, “Modulation of Intramitochondrial Free Ca2+Concentration by Antagonists of Na+-Ca2+Exchange,”Trends Pharmacol. Sci. 14(11):408-413, Nov. 1993.
Cox et al., “Selectivity of Inhibition of Na+-Ca2+Exchange of Heart Mitochondria by Benzothiazepine CGP-37157,”Cardiovasc. Pharmacol. 21(4):595-599, Apr. 1993.
Crompton and Andreeva, “On the Involvement of a Mitochondrial Pore in Reperfusion Injury,”Basic Res. Cardiol. 88(5):513-523, 1993.
Gunter and Gunter, “Transport of Calcium by Mitochondria,”J. Bioenerg. Biomembr. 26(5):471-485, Oct. 1994.
Kennedy et al., “Glucose-Stimulated Insulin Secretion Correlates With Changes in Mitochondrial and Cytosolic Ca2+in Aequorin-Expressing INS-1 Cells,”J. Clin. Invest. 98(11):2524-2538, Dec. 1, 1996.
Maechler et al., “Mitochondrial Activation Directly Triggers the Exocytosis of Insulin in Permeabilized Pancreatic β-cells,”EMBO J. 16(13):3833-3841, Jul. 1, 1997.
Magnus et al., “Model of β-cell Mitochondrial Calcium Handling and Electrical Activity. II. Mitochondrial Variables,”Am. J. Physiol. 274(4pt1):C1174-C1184, Apr. 1998.
Matlib et al., “A Specific Inhibitory Action of Certain Benzothiazepines and Benzodiazepines on the Sodium-Calcium Exchange Process of Heart and Brain Mitochondria,”Eur. J. Pharmacol. 89(3-4):327-328, May 6, 1983.
Matlib et al., “Selective Effects of Diltiazem, a Benzothiazepine Calcium Channel Blocker, and Diazepam, and other Benzodiazepines on the Na+/Ca2+Exchange Carrier System of Heart and Brain Mitochondria,”Life Sci. 32(25):2837-2842, Jun. 20, 1983.
Matlib, “Action of Bepridil, a New Calcium Channel Blocker on Oxidative Phosphorylation, Oligomycin-Sensitive Adenosine Triphosphatase Activity, Swelling, Ca++Uptake and Na+-Induced Ca++Release Processes of Rabbit Heart Mitochondria in Vitro,”J. Pharmacol. Exp. Ther. 233(2):376-381, May 1985.
Newgard et al., “Metabolic Coupling Factors in Pancreatic β-cell Signal Transduction,”Ann. Rev. Biochem. 64:689-719, 1995.
Rutter et al., “Regulation of NAD+-Linked Isocitrate Dehydrogenase and 2-Oxoglutarate Dehydrogenase by Ca2+Ions Within Toluene-Permeabilized Rat Heart Mitochondria. Interactions With Regulation by Adenine Nucleotides and NADH/NAD+Ratios,”Biochem. J. 252(1):181-189, May 15, 1988.
Rutter et al., “Stimulated Ca2+Influx Raises Mitochondrial Free Ca2+to Supramicromolar Levels in a Pancreatic β-Cell Line. Possible Role in Glucose and Agonist-Induced Insulin Secretion,”J. Biol. Chem. 268(30):22385-22390, Oct. 25, 1993.
White et al., “Mitochondria Accumulate Ca2+Following Intense Glutamate Stimulation of Cultured Rat Forebrain Neurones,”J. Physiol. 498(Pt 1):31-47, Jan. 1, 1997.
Zoratti et al., “Electrophysiology of the Inner Mitochondrial Membrane,”J. Bioenerget. Biomembr. 26(5):543-553, Oct. 1994.
Klosa, J. “Synthese Von Benzothiazepinonen, Einer Neuen Koerperklasse Synthesis of Benzothiazepinones, a New Class of Compounds,”Journal Fuer Praktische Chemie 3(1/2):5-18, 1967.
Pei, Y. et al., “Efficient Syntheses of Benzothiazepines as Antagonists for the Mitochondrial Sodium-Calcium Exchanger: Potential Therapeutics for Type II Diabetes,”Journal of Organic Chemistry 68(1):92-103, Nov. 2002.

Affiliated with

Also associated with

Rating

Compounds for inhibiting insulin secretion and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds for inhibiting insulin secretion and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds for inhibiting insulin secretion and methods... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3471151